Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study.
| Autor: | Hansel, Nadia N., Putcha, Nirupama, Han Woo, Peng, Roger, Diette, Gregory B., Fawzy, Ashraf, Wise, Robert A., Romero, Karina, Davis, Meghan F., Rule, Ana M., Eakin, Michelle N., Breysse, Patrick N., McCormack, Meredith C., Koehler, Kirsten, Woo, Han |
|---|---|
| Předmět: |
INDOOR air quality
OBSTRUCTIVE lung diseases AIR purification equipment CLINICAL trials EX-smokers RESPIRATORY diseases INDOOR air pollution prevention OBSTRUCTIVE lung disease diagnosis DISEASE progression RESEARCH AIR filters TREATMENT effectiveness COMPARATIVE studies RANDOMIZED controlled trials BLIND experiment QUESTIONNAIRES RESEARCH funding |
| Zdroj: | American Journal of Respiratory & Critical Care Medicine; 2/15/2022, Vol. 205 Issue 4, p421-430, 25p |
| Abstrakt: | Rationale: Indoor particulate matter is associated with worse chronic obstructive pulmonary disease (COPD) outcomes. It remains unknown whether reductions of indoor pollutants improve respiratory morbidity. Objectives: To determine whether placement of active portable high-efficiency particulate air cleaners can improve respiratory morbidity in former smokers. Methods: Eligible former smokers with moderate-to-severe COPD received active or sham portable high-efficiency particulate absolute air cleaners and were followed for 6 months in this blinded randomized controlled trial. The primary outcome was 6-month change in St. George's Respiratory Questionnaire (SGRQ). Secondary outcomes were exacerbation risk, respiratory symptoms, rescue medication use, and 6-minute-walk distance (6MWD). Intention-to-treat analysis included all subjects, and per-protocol analysis included adherent participants (greater than 80% use of air cleaner). Measurements and Main Results: A total of 116 participants were randomized, of which 84.5% completed the study. There was no statistically significant difference in total SGRQ score, but the active filter group had greater reduction in SGRQ symptom subscale (β, -7.7 [95% confidence interval (CI), -15.0 to -0.37]) and respiratory symptoms (Breathlessness, Cough, and Sputum Scale, β, -0.8 [95% CI, -1.5 to -0.1]); and lower rate of moderate exacerbations (incidence rate ratio, 0.32 [95% CI, 0.12-0.91]) and rescue medication use (incidence rate ratio, 0.54 [95% CI, 0.33-0.86]) compared with sham group (all P < 0.05). In per-protocol analysis, there was a statistically significant difference in primary outcome between the active filter versus sham group (SGRQ, β -4.76 [95% CI, -9.2 to -0.34]) and in moderate exacerbation risk, Breathlessness, Cough, and Sputum Scale, and 6MWD. Participants spending more time indoors were more likely to have treatment benefit. Conclusions: This is the first environmental intervention study conducted among former smokers with COPD showing potential health benefits of portable high-efficiency particulate absolute air cleaners, particularly among those with greater adherence and spending a greater time indoors. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|